Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistance. (2019)
Attributed to:
Novel strategies to improve the effectiveness of radiation and targeted therapies in lung cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.15252/emmm.201809982
PubMed Identifier: 31273933
Publication URI: http://europepmc.org/abstract/MED/31273933
Type: Journal Article/Review
Volume: 11
Parent Publication: EMBO molecular medicine
Issue: 7
ISSN: 1757-4676